Cyanovirin-N

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Script error: No such module "Unsubst". Cyanovirin-N (CV-N) is a protein produced by the cyanobacterium Nostoc ellipsosporum that displays virucidal activity against several viruses, including human immunodeficiency virus (HIV).[1] The cyanobacterial protein has strong anti-HIV neutralizing properties.[2] The virucidal activity of CV-N is mediated through specific high-affinity interactions with the viral surface envelope glycoproteins gp120 and gp41, as well as high-mannose oligosaccharides found on the HIV envelope.[3] In addition, CV-N is active against rhinoviruses, human parainfluenza virus, respiratory syncytial virus, and enteric viruses. The virucidal activity of CV-N against influenza virus is directed towards viral haemagglutinin.[4]

The blue-green alga Nostoc ellipsosporum naturally contains CV-N. The National Cancer Institute (NCI) in the United States of America carried out the initial isolation and characterization of this protein in 1999.[5] The use of CV-N as an antiviral drug, particularly against HIV, has since been the subject of investigation. Its ability to bind to the HIV-encapsulating glycoprotein gp120 has been demonstrated in several studies, which has led to the development of CV-N-based therapies and preventatives.[5]

Structure

CV-N is a lengthy, mostly beta-sheet protein that displays internal two-fold pseudosymmetry. The fundamental atomic root-mean-square of the two sequence repeats (1-50 and 51-101) differs by 1.3 Å while sharing 32% of the same sequence. The total fold depends on a number of interactions between the two repetitions; therefore, they do not actually belong in separate domains.[6] CV-N has a complex fold of a tandem repeat duplication of two homologous motifs, comprising three-stranded beta-sheet and beta-hairpins.[7]

References

  1. Script error: No such module "Citation/CS1".
  2. Dey, Barna, Danica L. Lerner, Paolo Lusso, Michael R. Boyd, John H. Elder, and Edward A. Berger. “Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses.” Journal of Virology 74, no. 10 (2000): 4562–69. https://doi.org/10.1128/jvi.74.10.4562-4569.2000.)
  3. Script error: No such module "Citation/CS1".
  4. Script error: No such module "Citation/CS1".
  5. a b Script error: No such module "Citation/CS1".
  6. Script error: No such module "Citation/CS1".
  7. Script error: No such module "Citation/CS1".

External links

Template:HIVpharm